Economic Evaluation of Adolescent Addiction Programs: Methodologic Challenges and Recommendations

Journal of Adolescent Health

Volumn 43, Issue 6, 2008, Pages 529-539

  Homer, Jenny F ^a   Drummond, Michael F ^b   French, Michael T ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Adolescent addiction; Benefits; Costs; Economic evaluation; Substance abuse programs

Indexed keywords

ADDICTION; CLINICAL EVALUATION; COGNITIVE THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE TREATMENT; ECONOMIC EVALUATION; FOLLOW UP; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MEDICAL RESEARCH; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUBSTANCE ABUSE;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; COSTS AND COST ANALYSIS; FOLLOW-UP STUDIES; HUMANS; MODELS, THEORETICAL; RESEARCH DESIGN; SUBSTANCE-RELATED DISORDERS;

EID: 56249106187     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2008.06.022     Document Type: Review

References (60)

1. Henggeler S.W., Clingempeel W.G., Brondino M.J., et al. Four year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 41 (2002) 868-874
2. Liddle H.A. Family-based therapies for adolescent alcohol and drug use: Research contributions and future research needs. Addiction 99 Suppl 2 (2004) 76-92
3. Muck R., Zempolich K.A., Titus J.C., et al. An overview of the effectiveness of adolescent substance abuse treatment models. Youth Soc 33 (2001) 143-168
4. Williams R.J., Chang S.Y., and Addiction Centre Adolescent Research Group. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol Sci Pract 7 (2000) 138-166
5. Morral A.R., Mccaffrey D.F., and Ridgeway G. Effectiveness of community-based treatment for substance-abusing adolescents: 12-Month outcomes of youths entering Phoenix Academy or Alternative Probation Dispositions. Psychol Addict Behav 18 (2004) 257-268
6. Hser Y., Grella C.E., Hubbard R.L., et al. An evaluation of drug treatments for adolescents in 4 U.S. cities. Arch Gen Psychiatry 58 (2001) 689-695
7. Dennis M.L., Godley S.H., Diamond G., et al. The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials. J Subst Abuse Treat 27 (2004) 197-213
8. Dennis M.L., Dawud-Noursi S., Muck R., et al. The need for developing and evaluating adolescent treatment models. In: Stevens S.J., and Morral A.R. (Eds). Adolescent Substance Abuse Treatment in the United States: Exemplary Models from a National Evaluation Study (2002), Haworth Press, Binghamton, NY 3-34
9. Waldron H.B., and Kaminer Y. On the learning curve: The emerging evidence supporting cognitive-behavioural therapies for adolescent substance abuse. Addiction 99 Suppl 2 (2004) 93-105
10. Rowe C.L., and Liddle H.A. Treating adolescent substance abuse: State of the science. In: Liddle H.A., and Rowe C.L. (Eds). Adolescent Substance Abuse Research and Clinical Advances (2006), Cambridge University Press, New York, NY 1-22
11. Kraft M.K., Schubert K., Pond A., et al. Adolescent treatment services: The context of care. In: Liddle H.A., and Rowe C.L. (Eds). Adolescent Substance Abuse Research and Clinical Advances (2006), Cambridge University Press, New York, NY 174-188
12. SAMSHA. National Survey on Drug Use and Health: Table G.34-Needed and Received Treatment for an Illicit Drug or Alcohol Problem in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentage, 2005 and 2006 [online] Available at www.oas.samhsa.gov/NSDUH/2K6NSDUH/App.htm#TabG-34. Accessed August 14, 2008.
13. Drummond M.F., Sculpher M.J., Torrance G.W., et al. Methods for the Economic Evaluation of Health Care Programmes (2005), Oxford University Press, Oxford, UK
14. Sheidow A.J., Bradford W.D., Henggeler S.W., et al. Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. Psychiatr Serv 55 (2004) 548-554
15. King R.D., Gaines L.S., Lambert E.W., et al. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: Frequency, recognition, cost, and outcomes. J Behav Health Serv Res 27 (2000) 417-430
16. Foster E.M., and Bickman L. Refining the costs analyses of the Fort Bragg Evaluation: The impact of cost offset and cost shifting. Ment Health Serv Res 2 (2000) 13-25
17. Parthasarathy S., and Weisner C. Health care services use by adolescents with intakes into an outpatient alcohol and drug treatment program. Am J Addict 15 (2006) 113-121
18. Roebuck M.C., French M.T., and McLellan A.T. DATStats: Summary results from 85 completed Drug Abuse Treatment Cost Analysis Programs (DATCAPs). J Subst Abuse Treat 25 (2003) 51-57
19. Zavala S., French M.T., Henderson C.E., et al. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments. J Subst Abuse Treat 29 (2005) 191-205
20. Balsa A, Homer J, French M, et al. Substance use, education, employment, and criminal activity outcomes of adolescents in outpatient chemical dependency programs. J Behav Health Serv Res (in press).
21. Freeborn D.K., Beaudet M.P., Mullooly J.P., et al. Adolescent chemical dependency treatment in an HMO. HMO Pract 5 (1991) 44-50
22. Koenig L., Denmead G., Nguyen R., et al. The Costs and Benefits of Substance Abuse Treatment: Findings from the National Treatment Improvement Evaluation Study (NTIES) (1999), Center for Substance Abuse Treatment, Rockville, MD
23. French M.T., Zavala S.K., McCollister K.E., Waldron, et al. Cost-effectiveness analysis (CEA) of four interventions for adolescents with a substance use disorder. J Subst Abuse Treat 34 (2008) 272-281
24. McCollister KE, French MT, Sheidow A, et al. Estimating the differential costs of criminal activity among juvenile drug court participants: Challenges and recommendations. J Behav Health Serv Res (in press).
25. French M.T., Roebuck M.C., Dennis M.L., et al. Outpatient marijuana treatment for adolescents-economic evaluation of a multisite experiment. Eval Rev 27 (2003) 421-459
26. Schoenwald S.K., Ward D.M., Henggeler S.W., et al. Multisystemic therapy treatment of substance abusing or dependent adolescent offenders: Costs of reducing incarceration, inpatient, and residential placement. J Child Fam Stud 5 (1996) 431-444
27. Brown S.A. Measuring youth outcomes from alcohol and drug treatment. Addiction 99 Suppl 2 (2004) 38-46
28. Aarons G., Brown S., Hough R., et al. Prevalence of adolescent substance use disorders across five sectors of care. J Am Acad Child Adolesc Psychiatry 40 (2001) 419-426
29. th Edition (2005), Pearson Education, Boston, MA
30. Guyatt G.H., Haynes R.B., Jaeschke R.Z., et al. for the Evidence-Based Medicine Working Group. Users' guides to the medical literature XXV. Evidence-based medicine: Principles for applying the users' guides to patient care. JAMA 284 (2000) 1290-1296
31. Heckman J.J. Randomization as an instrumental variable. Rev Econ Stat 78 (1996) 336-341
32. rd edition (2003), Jones and Bartlett Publishers, Boston, MA
33. Godley M.D., Godley S.H., Dennis M.L., et al. Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. J Subst Abuse Treat 23 (2002) 21-32
34. Liddle H.A., Dakof G.A., and Parker K. Multidimensional family therapy for adolescent substance abuse: Results of a randomized controlled trial. Am J Drug Alcohol Abuse 27 (2001) 651-658
35. Waldron H.B., Slesnick N.M., Brody J.L., et al. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol 69 (2001) 802-813
36. Schulz K.F., Chalmers I., Hayes R.J., et al. Empirical evidence of bias: Dimensions of methodologic quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
37. Brown S.A., D'Amico E.J., McCarthy D.M., et al. Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol 62 (2001) 381-388
38. Godley S.H., Dennis M.L., Godley M.D., et al. Thirty-month relapse trajectory cluster groups among adolescents discharged from out-patient treatment. Addiction 99 Suppl 2 (2004) 129-139
39. Chung T., Maisto S.A., Cornelius J.R., et al. Adolescents' alcohol and drug use trajectories in the year following treatment. J Stud Alcohol 65 (2004) 105-114
40. Dennis M.L., Scott C.K., Funk R., et al. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat 28 Suppl 1 (2005) S51-S62
41. Donner A. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc Ser C Appl Stat 47 (1998) 95-113
42. Gil A.G., Wagner E.F., and Tubman J.G. Culturally sensitive substance abuse intervention for Hispanic and African American adolescents: Empirical examples from the Alcohol Treatment Targeting Adolescents in Need (ATTAIN) Project. Addiction 99 Suppl 2 (2004) 140-150
43. McClellan M., McNeil B.J., and Newhouse J.P. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality?. JAMA 272 (1994) 859-866
44. Goldman D.P., Bhattacharya J., McCaffrey D.F., et al. Effect of insurance on mortality in an HIV-positive population in care. J Am Stat Assoc 96 (2001) 883-894
45. Buxton M.J., Drummond M.F., Van Hout B.A., et al. Modeling in economic evaluation: An unavoidable fact of life. Health Econ 6 (1997) 217-227
46. Mark D.B., Hlatky M.A., Califf R.M., et al. Cost-effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 332 (1995) 1418-1424
47. French M.T., Roebuck M.C., Dennis M.L., et al. The economic cost of outpatient marijuana treatment for adolescents: Findings from a multi-site field experiment. Addiction 97 Suppl 1 (2002) 84-97
48. Salome H.J., French M.T., Miller M., et al. Estimating the client costs of addiction treatment: First findings from the Client Drug Abuse Treatment Cost Analysis Program (Client DATCAP). Drug Alcohol Depend 71 (2003) 195-206
49. Borisova N.N., and Goodman A.C. Measuring the value of time for methadone maintenance clients: Willingness to pay, willingness to accept, and the wage rate. Health Econ 12 (2003) 323-334
50. Kirby K.C., Dugosh K.L., Benishek L.A., et al. The significant other checklist: Measuring the problems experienced by family members of drug users. Addict Behav 30 (2005) 29-47
51. Grella C.E., Hser Y., Joshi V., et al. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 189 (2001) 384-392
52. Whitmore E.A., Mikulich S.K., Ehlers K.M., et al. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug Alcohol Depend 59 (2000) 131-141
53. Cohen M.A. The monetary value of saving a high-risk youth. J Quantitat Criminol 14 (1998) 5-33
54. Sindelar J.L., Jofre-Bonet M., French M.T., et al. Cost-effectiveness analysis of addiction treatment: Paradoxes of multiple outcomes. Drug Alcohol Depend 73 (2004) 41-50
55. Domino M.E., Burns B.J., Silva S.G., et al. Cost-effectiveness of treatments for adolescent depression: Results from TADS. Am J Psychiatry 165 (2008) 588-596
56. Lynch F.L., Hornbrook M., Clarke G.N., et al. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry 62 (2005) 1241-1248
57. Mauskopf J.A., Paul J.E., Grant D.M., et al. The role of cost-consequence analysis in health care decision making. Pharmacoeconomics 13 (1998) 277-288
58. Ettner S.L., Huang D., Evans E., et al. Benefit cost in the California treatment outcome project: Does substance abuse treatment pay for itself?. Health Serv Res 41 (2006) 192-213
59. Olmstead T.A., Sindelar J.L., and Petry N.M. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend 87 (2007) 175-182
60. Henggeler S.W., Pickrel S.G., and Brondino M.J. Multisystemic treatment of substance abusing and dependent delinquents: Outcomes, treatment fidelity, and transportability. Ment Health Serv Res 1 (1999) 171-184